Citadel Advisors’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.46M | Buy |
147,800
+112,700
| +321% | +$2.04M | ﹤0.01% | 4984 |
|
|
2025
Q4 | $498K | Buy |
35,100
+18,000
| +105% | +$341K | ﹤0.01% | 9024 |
|
|
2025
Q3 | $423K | Sell |
17,100
-10,200
| -37% | -$228K | ﹤0.01% | 9537 |
|
|
2025
Q2 | $619K | Buy |
27,300
+9,500
| +53% | +$225K | ﹤0.01% | 8127 |
|
|
2025
Q1 | $540K | Sell |
17,800
-5,800
| -25% | -$221K | ﹤0.01% | 8305 |
|
|
2024
Q4 | $936K | Sell |
23,600
-66,100
| -74% | -$2.98M | ﹤0.01% | 7164 |
|
|
2024
Q3 | $5.69M | Buy |
89,700
+69,300
| +340% | +$5M | ﹤0.01% | 3748 |
|
|
2024
Q2 | $1.38M | Buy |
20,400
+1,800
| +10% | +$126K | ﹤0.01% | 6006 |
|
|
2024
Q1 | $1.47M | Sell |
18,600
-7,400
| -28% | -$605K | ﹤0.01% | 6123 |
|
|
2023
Q4 | $2.02M | Buy |
26,000
+2,200
| +9% | +$163K | ﹤0.01% | 5329 |
|
|
2023
Q3 | $1.67M | Buy |
23,800
+4,100
| +21% | +$306K | ﹤0.01% | 5544 |
|
|
2023
Q2 | $1.57M | Sell |
19,700
-3,100
| -14% | -$224K | ﹤0.01% | 5606 |
|
|
2023
Q1 | $1.65M | Buy |
22,800
+17,900
| +365% | +$1.4M | ﹤0.01% | 5737 |
|
|
2022
Q4 | $403K | Sell |
4,900
-8,900
| -64% | -$734K | ﹤0.01% | 8697 |
|
|
2022
Q3 | $1.08M | Buy |
+13,800
| New | +$1.1M | ﹤0.01% | 6842 |
|
|
2022
Q2 | – | Sell |
-12,600
| Closed | -$826K | – | 12764 |
|
|
2022
Q1 | $826K | Sell |
12,600
-3,100
| -20% | -$180K | ﹤0.01% | 8147 |
|
|
2021
Q4 | $953K | Buy |
15,700
+9,300
| +145% | +$555K | ﹤0.01% | 8098 |
|
|
2021
Q3 | $408K | Buy |
+6,400
| New | +$404K | ﹤0.01% | 10360 |
|
|
2021
Q2 | – | Sell |
-111,100
| Closed | -$6.35M | – | 13574 |
|
|
2021
Q1 | $6.35M | Buy |
111,100
+59,900
| +117% | +$3.24M | ﹤0.01% | 3772 |
|
|
2020
Q4 | $2.57M | Buy |
+51,200
| New | +$2.04M | ﹤0.01% | 4840 |
|
|
2020
Q3 | – | Sell |
-11,700
| Closed | -$294K | – | 9992 |
|
|
2020
Q2 | $294K | Sell |
11,700
-1,300
| -10% | -$32.4K | ﹤0.01% | 7931 |
|
|
2020
Q1 | $239K | Buy |
13,000
+6,600
| +103% | +$189K | ﹤0.01% | 7708 |
|
|
2019
Q4 | $213K | Sell |
6,400
-12,400
| -66% | -$389K | ﹤0.01% | 8074 |
|
|
2019
Q3 | $584K | Sell |
18,800
-16,900
| -47% | -$515K | ﹤0.01% | 6495 |
|
|
2019
Q2 | $1.25M | Sell |
35,700
-18,300
| -34% | -$592K | ﹤0.01% | 5332 |
|
|
2019
Q1 | $1.58M | Buy |
54,000
+13,900
| +35% | +$394K | ﹤0.01% | 4843 |
|
|
2018
Q4 | $1.03M | Sell |
40,100
-4,100
| -9% | -$142K | ﹤0.01% | 5255 |
|
|
2018
Q3 | $1.56M | Buy |
44,200
+30,600
| +225% | +$1.22M | ﹤0.01% | 4812 |
|
|
2018
Q2 | $556K | Buy |
13,600
+6,400
| +89% | +$258K | ﹤0.01% | 6194 |
|
|
2018
Q1 | $282K | Sell |
7,200
-4,900
| -40% | -$180K | ﹤0.01% | 6846 |
|
|
2017
Q4 | $395K | Buy |
+12,100
| New | +$419K | ﹤0.01% | 6021 |
|
|
2017
Q2 | – | Sell |
-10,200
| Closed | -$445K | – | 7402 |
|
|
2017
Q1 | $445K | Sell |
10,200
-4,000
| -28% | -$162K | ﹤0.01% | 5217 |
|
|
2016
Q4 | $470K | Buy |
14,200
+600
| +4% | +$23.3K | ﹤0.01% | 4997 |
|
|
2016
Q3 | $674K | Buy |
13,600
+900
| +7% | +$46.9K | ﹤0.01% | 4392 |
|
|
2016
Q2 | $704K | Sell |
12,700
-8,200
| -39% | -$480K | ﹤0.01% | 4021 |
|
|
2016
Q1 | $1.15M | Buy |
20,900
+6,500
| +45% | +$371K | ﹤0.01% | 3313 |
|
|
2015
Q4 | $899K | Sell |
14,400
-10,400
| -42% | -$677K | ﹤0.01% | 3707 |
|
|
2015
Q3 | $1.64M | Buy |
24,800
+11,100
| +81% | +$854K | ﹤0.01% | 3193 |
|
|
2015
Q2 | $1.07M | Buy |
13,700
+13,100
| +2,183% | +$943K | ﹤0.01% | 3873 |
|
|
2015
Q1 | $43K | Sell |
600
-4,300
| -88% | -$276K | ﹤0.01% | 7467 |
|
|
2014
Q4 | $300K | Buy |
4,900
+3,200
| +188% | +$186K | ﹤0.01% | 5425 |
|
|
2014
Q3 | $82K | Buy |
1,700
+500
| +42% | +$24.4K | ﹤0.01% | 6571 |
|
|
2014
Q2 | $55K | Buy |
+1,200
| New | +$52.7K | ﹤0.01% | 6687 |
|
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
Citadel Advisors's ACHC Position: Q1 2026 in Review
Citadel Advisors increased its Acadia Healthcare (ACHC) stake by 100% in Q1 2026, buying an estimated $24.6M and bringing the position to 2,716,425 shares worth $63.5M. The position accounts for 0.01% of the portfolio, ranked #1145.
Citadel Advisors first reported a position in ACHC in Q3 2013 and has held it in 49 quarters since. The position peaked at $161M in Q2 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- Citadel Advisors held 2,716,425 shares of Acadia Healthcare worth $63.5M as of Q1 2026.
- Citadel Advisors bought 1,361,142 Acadia Healthcare shares in Q1 2026, an estimated $24.6M.
- Acadia Healthcare made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1145 holding.
- Citadel Advisors first reported a position in Acadia Healthcare in Q3 2013 and has held it in 49 quarters since.
- Citadel Advisors's Acadia Healthcare position peaked at $161M in Q2 2024.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.